FDA cracks down on sales of Juul tobacco products to minors
(Reuters) – The U.S. Food and Drug Administration on Tuesday said it launched a crackdown on the sale of e-cigarettes and tobacco products to minors, particularly those developed by Juul…
Jilted Akorn sues Fresenius over deal termination
FRANKFURT (Reuters) – U.S. generic drugmaker Akorn is taking former suitor Fresenius to court after the German healthcare group canceled their $4.75 billion takeover agreement. FILE PHOTO: Fresenius headquarters in…
FDA declines to approve Pfizer’s biosimilar to Roche’s cancer drug
(Reuters) – Pfizer Inc said on Monday the U.S. Food and Drug Administration (FDA) declined to approve the company’s biosimilar to Roche’s breast cancer drug, Herceptin, and sought additional technical…
Canada seeks U.S. help to solve EpiPen shortage
TORONTO (Reuters) – Canada said on Tuesday it is working with the U.S. Food and Drug Administration to access supplies of Mylan N.V.’s EpiPen emergency allergy antidote amid a growing…
FDA approves Ultragenyx’s drug for rare form of rickets
(Reuters) – The U.S. Food and Drug Administration has approved Ultragenyx Pharmaceutical Inc’s treatment for a rare and inherited form of rickets, a condition that causes weak bones, the agency…
Biotech M&A rolls on as Alex ion snaps up Wilson for $855 mln
(Reuters) – Alex ion Pharmaceuticals has agreed to buy Sweden’s Wilson Therapeutics for 7.1 billion Swedish crowns ($855 million), boosting its line-up of rare disease drugs as a wave of…
Pfizer signs deal with Allogene to develop cancer cell therapy
(Reuters) – Pfizer Inc said on Tuesday it signed an agreement with Allogene Therapeutics, a company formed by a consortium in which the drugmaker will hold a 25 percent stake,…
FDA panel backs Pfizer’s Xeljanz as bowel disease treatment
(Reuters) – Pfizer Inc’s Xeljanz should be approved to treat patients with moderate to severe ulcerative colitis, a chronic bowel disease, a U.S. Food and Drug Administration (FDA) advisory committee…
U.S. says Idaho cannot sell health plans not compliant with Obamacare
WASHINGTON (Reuters) – A U.S. government agency on Thursday said Idaho could not allow health insurers to sell plans that do not comply with Obamacare, a sign that the Trump…